200
Participants
Start Date
August 7, 2018
Primary Completion Date
November 30, 2022
Study Completion Date
January 20, 2023
PAPILOCARE
"Papilocare®: Vaginal Gel based on Coriolus versicolor, medical device class IIa.~Route of administration: topical (vaginal). Papilocare® consists of the following ingredients: hyaluronic acid niosomes, β-glucans (magnolol, honokiol and carboxymethyl betaglucan) niosomes, BioEcolia® (Alpha-oligoglycan), Coriolus versicolor, Azadirachta indica (Neem) extract, Centella asiatica and Aloe vera."
PLACEBO
The placebo consists of a carrier gel with the absence of the active ingredients of Papilocare®.
Hospital Universitario Nuestra Señora de la Candelaria, Santa Cruz de Tenerife
Procare Health Iberia S.L.
INDUSTRY